Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Essential Pharma appoints Becki Morison as Chief Executive Officer
Pharmaceutical executive brings 25+ years of international commercial leadership and rare disease experience Egham, UK – 18 June 2026 – Essential Pharma ('Essential' or 'the Company'), a global pharmaceutical company developing and…
Cure for certain cancers is 'realistic' goal in next decade, pharma lead says
A cure for cancer could be on the horizon in the next decade, according to experts. During the WSJ Leadership Institute CEO Summit in London last week, Johnson & Johnson Chairman and CEO Joaquin Duato reflected on the pharmaceutical company's…
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
iShares U.S. Pharmaceuticals ETF (IHE 0.86%) offers a more stable, dividend-focused path into healthcare compared to the high-volatility, equal-weighted growth profile of the State Street SPDR S&P Biotech ETF (XBI +2.91%). Both funds launched in…
India bans OTC cough syrups; Rs 5,700 crore pharma segment faces volume pressure
The cough and cold liquids market of the Indian Pharmaceutical Industry, valued at approximately Rs 5,700 crore, faces a serious risk of volume decline as the Indian government banned over-the-counter (OTC) sales of all syrups, including cough…
BridgeBio Pharma, Inc. $BBIO Position Lessened by Cormorant Asset Management LP
Cormorant Asset Management LP cut its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 14.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional…
Cormorant Asset Management LP Purchases Shares of 100,000 Ascendis Pharma A/S $ASND
Cormorant Asset Management LP bought a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 100,000…
BridgeBio Pharma, Inc. $BBIO Shares Sold by Boone Capital Management LLC
Boone Capital Management LLC lowered its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 59.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…
Artia Global Partners LP Increases Position in Ascendis Pharma A/S $ASND
Artia Global Partners LP boosted its holdings in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 44.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,740 shares of the…
BridgeBio Pharma, Inc. $BBIO Shares Sold by Cinctive Capital Management LP
Cinctive Capital Management LP reduced its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 26.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned…
Janus Henderson Group PLC Acquires 2,259,378 Shares of BridgeBio Pharma, Inc. $BBIO
Janus Henderson Group PLC raised its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 25.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional…
Catalio Capital Management LP Sells 25,689 Shares of Ascendis Pharma A/S $ASND
Catalio Capital Management LP trimmed its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 17.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm…
Perceptive Advisors LLC Has $230.60 Million Stock Holdings in Ascendis Pharma A/S $ASND
Perceptive Advisors LLC lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 0.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,081,421 shares…
Ishara Investments LP Makes New $2.75 Million Investment in BridgeBio Pharma, Inc. $BBIO
Ishara Investments LP purchased a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 36,000 shares of the…
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…
Pfizer CFO Dave Denton to step down in August
Michael Nagle | Bloomberg | Getty Images Pfizer said on Thursday that finance chief Dave Denton will step down and leave the company on August 15 to take a role in the consumer goods…
Receive a Daily briefing on Pharma Industry News
Get Started